Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1977 1
1978 8
1980 1
1982 2
1983 1
1990 2
1994 1
1995 3
1996 3
1997 4
1999 4
2000 2
2001 4
2002 2
2003 3
2004 3
2005 9
2006 8
2007 13
2008 10
2009 12
2010 12
2011 12
2012 24
2013 12
2014 21
2015 24
2016 13
2017 5
2018 3
2019 6
2020 3
2021 2
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

201 results
Results by year
Filters applied: . Clear all
Page 1
Introduction to Magnetic Resonance Imaging for Neurologists.
Radue EW, Weigel M, Wiest R, Urbach H. Radue EW, et al. Continuum (Minneap Minn). 2016 Oct;22(5, Neuroimaging):1379-1398. doi: 10.1212/CON.0000000000000391. Continuum (Minneap Minn). 2016. PMID: 27740981 Free article. Review.
Oral ponesimod in relapsing-remitting multiple sclerosis: a randomised phase II trial.
Olsson T, Boster A, Fernández Ó, Freedman MS, Pozzilli C, Bach D, Berkani O, Mueller MS, Sidorenko T, Radue EW, Melanson M. Olsson T, et al. Among authors: radue ew. J Neurol Neurosurg Psychiatry. 2014 Nov;85(11):1198-208. doi: 10.1136/jnnp-2013-307282. Epub 2014 Mar 21. J Neurol Neurosurg Psychiatry. 2014. PMID: 24659797 Free PMC article. Clinical Trial.
A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis.
Kappos L, Radue EW, O'Connor P, Polman C, Hohlfeld R, Calabresi P, Selmaj K, Agoropoulou C, Leyk M, Zhang-Auberson L, Burtin P; FREEDOMS Study Group. Kappos L, et al. Among authors: radue ew. N Engl J Med. 2010 Feb 4;362(5):387-401. doi: 10.1056/NEJMoa0909494. Epub 2010 Jan 20. N Engl J Med. 2010. PMID: 20089952 Free article. Clinical Trial.
Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial.
Uccelli A, Laroni A, Ali R, Battaglia MA, Blinkenberg M, Brundin L, Clanet M, Fernandez O, Marriot J, Muraro P, Nabavi SM, Oliveri RS, Radue E, Ramo Tello C, Schiavetti I, Sellner J, Sorensen PS, Sormani MP, Wuerfel JT, Freedman MS; MESEMS investigators. Uccelli A, et al. Among authors: radue e. Lancet Neurol. 2021 Nov;20(11):917-929. doi: 10.1016/S1474-4422(21)00301-X. Lancet Neurol. 2021. PMID: 34687636
Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial.
Calabresi PA, Radue EW, Goodin D, Jeffery D, Rammohan KW, Reder AT, Vollmer T, Agius MA, Kappos L, Stites T, Li B, Cappiello L, von Rosenstiel P, Lublin FD. Calabresi PA, et al. Among authors: radue ew. Lancet Neurol. 2014 Jun;13(6):545-56. doi: 10.1016/S1474-4422(14)70049-3. Epub 2014 Mar 28. Lancet Neurol. 2014. PMID: 24685276 Clinical Trial.
MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials.
Barkhof F, Simon JH, Fazekas F, Rovaris M, Kappos L, de Stefano N, Polman CH, Petkau J, Radue EW, Sormani MP, Li DK, O'Connor P, Montalban X, Miller DH, Filippi M. Barkhof F, et al. Among authors: radue ew. Nat Rev Neurol. 2011 Dec 6;8(1):13-21. doi: 10.1038/nrneurol.2011.190. Nat Rev Neurol. 2011. PMID: 22143362 Review.
Myelin and axon pathology in multiple sclerosis assessed by myelin water and multi-shell diffusion imaging.
Rahmanzadeh R, Lu PJ, Barakovic M, Weigel M, Maggi P, Nguyen TD, Schiavi S, Daducci A, La Rosa F, Schaedelin S, Absinta M, Reich DS, Sati P, Wang Y, Bach Cuadra M, Radue EW, Kuhle J, Kappos L, Granziera C. Rahmanzadeh R, et al. Among authors: radue ew. Brain. 2021 Jul 28;144(6):1684-1696. doi: 10.1093/brain/awab088. Brain. 2021. PMID: 33693571 Free PMC article.
201 results